|
1
|
Kidd BL: Osteoarthritis and joint pain.
Pain. 123:6–9. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rogers MW and Wilder FV: The association
of BMI and knee pain among persons with radiographic knee
osteoarthritis: A cross-sectional study. BMC Musculoskelet Disord.
9:1632008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Y and Jordan JM: Epidemiology of
osteoarthritis. Clin Geriatr Med. 26:355–369. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le LT, Swingler TE and Clark IM: Review:
The role of microRNAs in osteoarthritis and chondrogenesis.
Arthritis Rheum. 65:1963–1974. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wheaton AJ, Borthakur A, Shapiro EM,
Regatte RR, Akella SV, Kneeland JB and Reddy R: Proteoglycan loss
in human knee cartilage: Quantitation with sodium MR
imaging-seasibility study. Radiology. 231:900–905. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clements KM, Price JS, Chambers MG, Visco
DM, Poole AR and Mason RM: Gene deletion of either
interleukin-1beta, interleukin-1beta-converting enzyme, inducible
nitric oxide synthase, or stromelysin 1 accelerates the development
of knee osteoarthritis in mice after surgical transection of the
medial collateral ligament and partial medial meniscectomy.
Arthritis Rheum. 48:3452–3463. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Murrell GA, Jang D and Williams RJ: Nitric
oxide activates metalloprotease enzymes in articular cartilage.
Biochem Biophys Res Commun. 206:15–21. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hashimoto S, Takahashi K, Amiel D, Coutts
RD and Lotz M: Chondrocyte apoptosis and nitric oxide production
during experimentally induced osteoarthritis. Arthritis Rheum.
41:1266–1274. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farrell AJ, Blake DR, Palmer RM and
Moncada S: Increased concentrations of nitrite in synovial fluid
and serum samples suggest increased nitric oxide synthesis in
rheumatic diseases. Ann Rheum Dis. 51:1219–1222. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vuolteenaho K, Moilanen T, Jalonen U,
Lahti A, Nieminen R, van Beuningen HM, van der Kraan PM and
Moilanen E: TGFbeta inhibits IL-1 -induced iNOS expression and NO
production in immortalized chondrocytes. Inflamm Res. 54:420–427.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gómez R, Scotece M, Conde J, Lopez V, Pino
J, Lago F, Gómez-Reino JJ and Gualillo O: Nitric oxide boosts TLR-4
mediated lipocalin 2 expression in chondrocytes. J Orthop Res.
31:1046–1052. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Takada K, Hirose J, Yamabe S, Uehara Y and
Mizuta H: Endoplasmic reticulum stress mediates nitric
oxide-induced chondrocyte apoptosis. Biomed Rep. 1:315–319. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Girolamo L, Kon E, Filardo G, Marmotti
AG, Soler F, Peretti GM, Vannini F, Madry H and Chubinskaya S:
Regenerative approaches for the treatment of early OA. Knee Surg
Sports Traumatol Arthrosc. 24:1826–1835. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lahiji A, Sohrabi A, Hungerford DS and
Frondoza CG: Chitosan supports the expression of extracellular
matrix proteins in human osteoblasts and chondrocytes. J Biomed
Mater Res. 51:586–595. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oprenyeszk F, Sanchez C, Dubuc JE, Maquet
V, Henrist C, Compère P and Henrotin Y: Chitosan enriched
three-dimensional matrix reduces inflammatory and catabolic
mediators production by human chondrocytes. PLoS One.
10:e01283622015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xia W, Liu P, Zhang J and Chen J:
Biological activities of chitosan and chitooligosaccharides. Food
Hydrocolloid. 25:170–179. 2011. View Article : Google Scholar
|
|
17
|
Jung WJ and Park RD: Bioproduction of
chitooligosaccharides: Present and perspectives. Mar Drugs.
12:5328–5356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kerch G: The potential of chitosan and its
derivatives in prevention and treatment of age-related diseases.
Mar Drugs. 13:2158–2182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Croisier F and Jérôme C: Chitosan-based
biomaterials for tissue engineering. Eur Polym J. 49:780–792. 2013.
View Article : Google Scholar
|
|
20
|
Chen Q, Liu SQ, Du YM, Peng H and Sun LP:
Carboxymethyl-chitosan protects rabbit chondrocytes from
interleukin-1beta-induced apoptosis. Eur J Pharmacol. 541:1–8.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu SQ, Qiu B, Chen LY, Peng H and Du YM:
The effects of carboxymethylated chitosan on metalloproteinase-1,
−3 and tissue inhibitor of metalloproteinase-1 gene expression in
cartilage of experimental osteoarthritis. Rheumatol Int. 26:52–57.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu H, Liu Z, Zhou H, Dai W, Chen S, Shu Y
and Feng J: JAK-STAT pathway modulates the roles of iNOS and COX-2
in the cytoprotection of early phase of hydrogen peroxide
preconditioning against apoptosis induced by oxidative stress.
Neurosci Lett. 529:166–171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dell'Albani P, Santangelo R, Torrisi L,
Nicoletti VG, De Vellis J and Giuffrida Stella AM: JAK/STAT
signaling pathway mediates cytokine-induced iNOS expression in
primary astroglial cell cultures. J Neurosci Res. 65:417–424. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Séguin CA and Bernier SM: TNFalpha
suppresses link protein and type II collagen expression in
chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways. J
Cell Physiol. 197:356–369. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Goff WL, O'Rourke KI, Johnson WC, Lacy PA,
Davis WC and Wyatt CR: The role of IL-10 in iNOS and cytokine mRNA
expression during in vitro differentiation of bovine mononuclear
phagocytes. J Interf Cytok Res. 18:139–149. 1998. View Article : Google Scholar
|
|
27
|
Bijlsma JW, Berenbaum F and Lafeber FP:
Osteoarthritis: An update with relevance for clinical practice.
Lancet. 377:2115–2126. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng S, Hunter DJ, Xu J and Ding C:
Monoclonal antibodies for the treatment of osteoarthritis. Expert
Opin Biol Ther. 16:1529–1540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma Z, Wang Y, Piao T and Liu J:
Echinocystic acid inhibits IL-1β-induced COX-2 and iNOS expression
in human osteoarthritis chondrocytes. Inflammation. 39:543–549.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng AW, Stabler TV, Bolognesi MP and
Kraus VB: Selenomethionine inhibits IL-1β inducible nitric oxide
synthase (iNOS) and cyclooxygenase 2 (COX2) expression in primary
human chondrocytes. Osteoarthritis Cartilage. 19:118–125. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ying X, Chen X, Cheng S, Shen Y, Peng L
and Xu HZ: Piperine inhibits IL-β induced expression of
inflammatory mediators in human osteoarthritis chondrocyte. Int
Immunopharmaco. 17:293–299. 2013. View Article : Google Scholar
|
|
32
|
Azuma K, Osaki T, Minami S and Okamoto Y:
Anticancer and anti-inflammatory properties of chitin and chitosan
oligosaccharides. J Funct Biomater. 6:33–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Martel-Pelletier J: Pathophysiology of
osteoarthritis. Osteoarthritis Cartilage. 12 Suppl A:S31–S33. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Namba A, Aida Y, Suzuki N, Watanabe Y,
Kawato T, Motohashi M, Maeno M, Matsumura H and Matsumoto M:
Effects of IL-6 and soluble IL-6 receptor on the expression of
cartilage matrix proteins in human chondrocytes. Connect Tissue
Res. 48:263–270. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin PM, Chen CC and Torzilli PA: Increased
stromelysin-1 (MMP-3), proteoglycan degradation (3B3- and 7D4) and
collagen damage in cyclically load-injured articular cartilage.
Osteoarthritis Cartilage. 12:485–496. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Porée B, Kypriotou M, Chadjichristos C,
Beauchef G, Renard E, Legendre F, Melin M, Gueret S, Hartmann DJ,
Malléin-Gerin F, et al: Interleukin-6 (IL-6) and/or soluble IL-6
receptor down-regulation of human type II collagen gene expression
in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and
of the binding activity of both factors to the COL2A1 promoter. J
Biol Chem. 283:4850–4865. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Imamura M, Targino RA, Hsing WT, Imamura
S, Azevedo RS, Boas LS, Tozetto-Mendoza TR, Alfieri FM, Filippo TR
and Battistella LR: Concentration of cytokines in patients with
osteoarthritis of the knee and fibromyalgia. Clin Interv Aging.
9:939–944. 2014.PubMed/NCBI
|
|
38
|
Rojas-Ortega M, Cruz R, Vega-López MA,
Cabrera-González M, Hernández-Hernández JM, Lavalle-Montalvo C and
Kouri JB: Exercise modulates the expression of IL-1β and IL-10 in
the articular cartilage of normal and osteoarthritis-induced rats.
Pathol Res Pract. 211:435–443. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li S, Wan J, Anderson W, Sun H, Zhang H,
Peng X, Yu Z, Wang T, Yan X and Smith W: Downregulation of IL-10
secretion by Treg cells in osteoarthritis is associated with a
reduction in Tim-3 expression. Biomed Pharmacothr. 79:159–165.
2016. View Article : Google Scholar
|
|
40
|
Müller RD, John T, Kohl B, Oberholzer A,
Gust T, Hostmann A, Hellmuth M, Laface D, Hutchins B, Laube G, et
al: IL-10 overexpression differentially affects cartilage matrix
gene expression in response to TNF-alpha in human articular
chondrocytes in vitro. Cytokine. 44:377–385. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Josephson K, Logsdon NJ and Walter MR:
Crystal structure of the IL-10/IL-10R1 complex reveals a shared
receptor binding site. Immunity. 15:35–46. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Carey AJ, Tan CK and Ulett GC:
Infection-induced IL-10 and JAK-STAT: A review of the molecular
circuitry controlling immune hyperactivity in response to
pathogenic microbes. JAKSTAT. 1:159–167. 2012.PubMed/NCBI
|
